Skip to content

LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)

LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) 1

LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs). This study has been completed. Sponsor: LEO Pharma. Information provided by (Responsible Party):. LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs). This study has been completed. Sponsor: LEO Pharma. Information provided by (Responsible Party): LEO Pharma. LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs). 2010Sep. LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs).

LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) 2LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) – Full Text V. LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs). Dates, Status, Enrollment. Verified by: LEO Pharma, March 2015. First Received: August 25, 2010 Last Updated: March 25, 2015. The purpose of this study is to compare the efficacy and safety of LEO 80185 topical suspension with the active components when used individually as monotherapy in the topical suspension vehicle (betamethasone dipropionate in the topical suspension vehicle, calcipotriol in the topical suspension vehicle) and with the topical suspension vehicle alone in the treatment of psoriasis vulgaris on the non-scalp regions of the body (trunk and/or limbs) in a large phase 3 study.

An international, multi-centre, prospective, non-controlled, open, single-group, 8-week trial in adolescent subjects (aged 12 to 16 years, 11 months) with scalp and body psoriasis. Title: LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis. Subjects With Mild Disease at Baseline) According to the Investigator’s Global Assessment (IGA) on the Trunk and Limbs at Week 4. BillTypeFrequencyCd 5 Late Charge(s) Only claim BillTypeFrequencyCd 7 Replacement of Prior Claim; 04010 SURGICAL PLACEMENT OF IMPLANT BODY: ENDOSTEAL IMPLANT Dental Procedure code.

Leo 80185 In The Treatment Of Psoriasis Vulgaris On The Non-scalp Regions Of The Body (trunk Limbs)

Effect Of Calcipotriol Plus Betamethasone Dipropionate Gel On The Hpa Axis And Calcium Metabolism In Adolescent Subjects (aged 12 To 16 Years, 11 Months) With Scalp And Body Psoriasis